Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide C pseudogene 9 (SNRPCP9)

Target
SNRPCP9
Molecular classification
Other, Pseudogene
01

Overview

Small nuclear ribonucleoprotein polypeptide C pseudogene 9 (SNRPCP9) is a nonfunctional DNA sequence that closely resembles the gene encoding small nuclear ribonucleoprotein polypeptide C (SNRPC), but has accumulated mutations or structural alterations that make it incapable of coding for a functional protein[3]. As a pseudogene, SNRPCP9 does not produce a receptor, enzyme, transporter, or other typical drug target, and is functionally inactive for protein coding. Some pseudogenes may have regulatory noncoding RNA functions, such as acting as microRNA decoys or being sources of regulatory small RNAs, but no such role has been documented for SNRPCP9 specifically[1][3]. In general, pseudogenes like SNRPCP9 are considered "genomic fossils" rather than functional macromolecular targets[1][2][3]. The entry is not a standard or canonical therapeutic target; pseudogenes are normally considered nonfunctional and not druggable as conventional receptors, enzymes, or other protein targets. Thus, SNRPCP9 is not a therapeutic target but rather a relic of genomic evolution[3]. In standard biomedical databases, functional annotation and drug development efforts do not focus on pseudogenes unless regulatory functions are specifically demonstrated, which has not been the case for SNRPCP9.

Other names
SNRPCP9
02

Biological functions

No direct biological function established for SNRPCP9 specificallyPotential for regulatory functions similar to other pseudogenes (e.g., acting as a source for regulatory RNAs)
03

Disease associations

No evidence linking SNRPCP9 specifically to diseasePseudogenes generally may be deregulated in cancer or can modulate disease-related gene expression in rare cases
04

Safety considerations

No typical pharmacological safety issuesTechnical challenges in assays due to sequence similarity to functional genes (e.g., misamplification in PCR)

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide C pseudogene 9 (SNRPCP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 9 (SNRPCP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call